Preparation method and preparation device of cross-linked sodium hyaluronate gel for injection

By using high molecular weight sodium hyaluronate and mixed crosslinking agent for crosslinking reaction and treatment, the problems of large amount of crosslinking agent and low crosslinking degree in the prior art were solved, and hyaluronic acid for injection with high crosslinking degree was achieved The preparation of sodium gel reduces cytotoxicity and prolongs degradation time.

CN118978721AInactive Publication Date: 2024-11-19ANHUI RUNLANG JILU BIOMEDICAL TECH CO LTD
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202411073492.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-06
Publication Date
2024-11-19
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

In the prior art, the amount of crosslinking agent for sodium hyaluronate is large and the crosslinking degree is not high, resulting in high cytotoxicity caused by residual crosslinking agent and insufficient degradation time.

Method used

Sodium hyaluronate with a molecular weight of more than 2 million was used for cross-linking reaction with mixed cross-linking agents (1,4-butanediol diglycidyl ether and polyethylene glycol 400), and was sterilized through cross-linking reaction, dialysis and high temperature humidity and heat , a sodium hyaluronate gel for injection with high crosslinking was prepared.

Benefits of technology

The amount of crosslinking agent is reduced, the degree of crosslinking is improved, the cytotoxicity of the crosslinking agent is reduced, and the degradation time of sodium hyaluronate in the body is extended, meeting the requirements of injection products.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118978721A_ABST
    Figure CN118978721A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of biological medicine, and particularly discloses a preparation method of cross-linked sodium hyaluronate gel for injection, and the preparation method comprises the following steps: S1, injecting alkali liquor into a cross-linking reaction tank, and dissolving sodium hyaluronate molecules in the alkali liquor to prepare a sodium hyaluronate solution; s2, adding a mixed cross-linking agent into the sodium hyaluronate solution, and carrying out cross-linking reaction to obtain cross-linked sodium hyaluronate gel; s3, dialyzing the cross-linked sodium hyaluronate gel, so as to prepare a water absorption swelling gel; and S4, grinding the water-swelling gel, and carrying out high-temperature moist heat sterilization to obtain the cross-linked sodium hyaluronate gel for injection. According to the preparation method and the preparation device of the cross-linked sodium hyaluronate gel for injection, sodium hyaluronate with the molecular weight larger than 2 million is adopted as a main raw material, the dosage of a cross-linking agent is reduced, the mixed cross-linking agent is adopted, and the cross-linking degree is improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the field of biomedicine technology, and in particular relates to a method and a device for preparing cross-linked sodium hyaluronate gel for injection. Background Art

[0002] Hyaluronic acid (HA) is a linear polyanionic mucopolysaccharide composed of repeated connection of D-glucuronic acid and N-acetyl-D-glucosamine disaccharide units. It is the most representative of mucopolysaccharides and is widely distributed in various parts of the human body. With its unique molecular structure and physical and chemical properties, it shows a variety of important physiological functions in the body, such as lubricating joints, regulating the permeability of blood vessel walls, regulating protein, water and electrolyte diffusion and operation, and promoting wound healing. In addition, HA has a special water-locking effect and is the best moisturizing substance found in nature. It is called the ideal natural moisturizing factor (NMF). For example, a 2% pure hyaluronic acid aqueous solution can firmly retain 98% water.

[0003] Hyaluronic acid was first isolated from the vitreous body of bovine eyes. It is widely present in the extracellular matrix of human connective tissue. Hyaluronic acid has no species and tissue specificity, has good tissue compatibility, and the body rarely produces an immune response to it. Human skin contains a large amount of hyaluronic acid, which is used to improve skin nutrition metabolism and make the skin soft, smooth and elastic. However, with the increase of age, the hyaluronic acid content in the skin will gradually decrease, causing skin wrinkles and atrophy. At this time, hyaluronic acid needs to be injected to play a role in filling and beauty. However, since the hyaluronic acid extracted from nature degrades very quickly when injected into the human body, and the degradation is completed within about 24 hours, sodium hyaluronate is generally cross-linked and injected subcutaneously to prolong the degradation time. The degradation time is closely related to the degree of cross-linking. Therefore, cross-linking modification of hyaluronic acid to prolong its degradation time in the body has important practical significance.

[0004] Currently, the commonly used cross-linking method is to cross-link sodium hyaluronate and cross-linking agents, such as 1,4-butanediol diglycidyl ether (BDDE), 1,2,7,8-diepoxyoctane (DEO), divinyl sulfone (DVS), etc., under alkaline conditions. The difference mainly lies in the ratio of sodium hyaluronate to cross-linking agent and the temperature of the cross-linking reaction. These conditions can control the degree of cross-linking to a certain extent, thereby controlling the degradation time.

[0005] Since 1,4-butanediol diglycidyl ether (BDDE) has relatively low toxicity and contains alkoxy bonds in the molecule, the alkoxy bonds can rotate freely after polymerization to make the material soft, making it particularly suitable for soft tissue filling. Therefore, most products on the market currently use 1,4-butanediol diglycidyl ether (BDDE) as a cross-linking agent for cross-linking.

[0006] The cross-linking agent currently used is a single cross-linking agent with a low degree of cross-linking and a large amount of cross-linking agent, which leads to high cytotoxicity caused by cross-linking agent residues. Summary of the invention

[0007] The purpose of the present invention is to overcome the above problems existing in the prior art and provide a method and a device for preparing a cross-linked sodium hyaluronate gel for injection, which uses sodium hyaluronate with a molecular weight greater than 2 million as the main raw material, reduces the amount of cross-linking agent, and uses a mixed cross-linking agent to increase the degree of cross-linking.

[0008] In order to achieve the above technical objectives and the above technical effects, the present invention is implemented through the following technical solutions:

[0009] The embodiment of the first aspect of the present invention provides a method for preparing a cross-linked sodium hyaluronate gel for injection, the preparation method comprising the following steps:

[0010] S1: injecting alkaline solution into a cross-linking reaction tank, dissolving sodium hyaluronate molecules in the alkaline solution, and preparing a sodium hyaluronate solution;

[0011] S2: adding a mixed cross-linking agent to the sodium hyaluronate solution to perform a cross-linking reaction to obtain a cross-linked sodium hyaluronate gel;

[0012] S3: dialyzing the cross-linked sodium hyaluronate gel to prepare a water-swellable gel;

[0013] S4: After the water-swelling gel is ground and sterilized by high-temperature wet heat, the cross-linked sodium hyaluronate gel for injection is obtained.

[0014] Furthermore, in step S1, the molecular weight of the sodium hyaluronate molecule is greater than 2 million Daltons.

[0015] Further, in step S1, the alkali solution is a sodium hydroxide solution with a concentration of 0.5-2%;

[0016] In the sodium hyaluronate solution, the mass ratio of sodium hyaluronate molecules to alkali solution is 1:(4-10).

[0017] Further, the mixed cross-linking agent is a mixture of 1,4-butanediol diglycidyl ether and polyethylene glycol 400 in any proportion;

[0018] In step S2, the mass ratio of the sodium hyaluronate molecules to the mixed cross-linking agent in the sodium hyaluronate solution is 12-40:1.

[0019] Furthermore, the specific process of step S2 is: after adding the mixed cross-linking agent to the sodium hyaluronate solution, heating to 30-50° C., stirring for 10-20 minutes, and then standing for 10-20 hours to obtain a cross-linked sodium hyaluronate gel.

[0020] Furthermore, the specific process of step S3 is as follows:

[0021] S31: Cut the cross-linked sodium hyaluronate gel into pieces with a volume of 1-3 cm 3 The block raw material is placed in a batching tank after cutting the cross-linked sodium hyaluronate gel;

[0022] S32: adding a buffer solution into the mixing tank, and continuously stirring the cut cross-linked sodium hyaluronate gel in the mixing tank at a rate of 5-20 r / min;

[0023] S33: After stirring for 6 hours, the buffer solution in the batching tank is discharged to complete a single dialysis process;

[0024] S34: Repeat steps S32-S336-10 times to obtain a water-absorbing and swelling gel.

[0025] Further, the buffer solution is a phosphate buffer solution containing sodium chloride;

[0026] The mass fraction of sodium chloride in the buffer solution is 0.5-1.5%.

[0027] Furthermore, the specific process of step S4 is: putting the water-swelling gel into a colloid mill for grinding, grinding for 2-3 times, each grinding for 10-20 minutes, and after the grinding, sterilizing the ground water-swelling gel at 115-125° C. for 10-20 minutes to obtain a cross-linked sodium hyaluronate gel for injection.

[0028] The embodiment of the second aspect of the present invention provides a preparation device of a preparation method of a cross-linked sodium hyaluronate gel for injection, comprising a batching tank, a cleaning tank, a saline tank 1, a saline tank 2, a saline pump 1 and a saline pump 2, wherein the saline tank 1 and the saline tank 2 are both connected to the water inlet end of the saline pump 1 through a pipeline, and the discharge ends of the saline pump 1 and the saline pump 2 are both connected to the batching tank, and the discharge end of the cleaning tank is connected to the water inlet end of the saline pump 2;

[0029] The bottom of the batching tank is connected with a drain pipe, and a drain valve is arranged on the drain pipe;

[0030] The feed inlets of the brine tank 1 and the brine tank 2 are both connected with pure water delivery pipelines.

[0031] Furthermore, the preparation device also includes a cross-linking reaction tank.

[0032] Compared with the prior art, the present invention has the following beneficial effects:

[0033] 1. The present invention provides a method for preparing a cross-linked sodium hyaluronate gel for injection, which uses sodium hyaluronate with a molecular weight greater than 2 million as the main raw material, reduces the amount of cross-linking agent, and uses a mixed cross-linking agent to increase the degree of cross-linking.

[0034] 2. The present invention also provides a preparation device for a method for preparing a cross-linked sodium hyaluronate gel for injection, which is used for preparing a cross-linked sodium hyaluronate gel for injection. The preparation device ensures that in the method for preparing the cross-linked sodium hyaluronate gel for injection, the cross-linking reaction and dialysis are carried out under closed conditions, thereby reducing the possibility of environmental microbial contamination, thereby ensuring that the prepared cross-linked sodium hyaluronate gel for injection meets the preparation requirements of injectable products.

[0035] 3. In the present invention, sodium hyaluronate with a molecular weight greater than 2 million Daltons is used as the main raw material, and the prepared cross-linked sodium hyaluronate gel for injection has a higher degree of cross-linking and can reduce the amount of cross-linking agent required.

[0036] 4. In the present invention, a mixture of 1,4-butanediol diglycidyl ether (BDDE) and polyethylene glycol 400 (PEG400) is used as a cross-linking agent, which has a higher degree of cross-linking and has a lower cytotoxicity caused by the cross-linking agent residue.

[0037] 5. In the present invention, during the dialysis process, multiple immersions are used to allow the cross-linked sodium hyaluronate gel to absorb water and swell, thereby adjusting the osmotic pressure and pH of the cross-linked sodium hyaluronate gel while removing the uncross-linked cross-linking agent in the cross-linked sodium hyaluronate gel. BRIEF DESCRIPTION OF THE DRAWINGS

[0038] The drawings described herein are used to provide a further understanding of the present invention and constitute a part of this application. The exemplary embodiments of the present invention and their descriptions are used to explain the present invention and do not constitute an improper limitation of the present invention. In the drawings:

[0039] Figure 1 It is a structural schematic diagram provided by an embodiment of the second aspect of the present invention.

[0040] Among them, the figures are marked as: 1. batching tank; 2. cleaning tank; 3. brine tank one; 4. brine tank two; 5. brine pump one; 6. brine pump two. DETAILED DESCRIPTION

[0041] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0042] In the description of the present invention, it should be understood that the terms "opening", "upper", "lower", "thickness", "top", "middle", "length", "inside", "all around" and the like indicating orientation or positional relationship are only for the convenience of describing the present invention and simplifying the description, rather than indicating or implying that the components or elements referred to must have a specific orientation, be constructed and operated in a specific orientation, and therefore should not be understood as limiting the present invention.

[0043] The embodiment of the first aspect of the present invention provides a method for preparing a cross-linked sodium hyaluronate gel for injection, the preparation method comprising the following steps:

[0044] S1: injecting alkali solution into a cross-linking reaction tank, dissolving sodium hyaluronate molecules with a molecular weight greater than 2 million Daltons in the alkali solution to prepare a sodium hyaluronate solution; wherein the alkali solution is a sodium hydroxide solution with a concentration of 0.5-2%;

[0045] In the sodium hyaluronate solution, the mass ratio of sodium hyaluronate molecules to alkali solution is 1:(4-10);

[0046] S2: adding a mixed cross-linking agent to the sodium hyaluronate solution to carry out a cross-linking reaction to obtain a cross-linked sodium hyaluronate gel; wherein the mixed cross-linking agent is a mixture of 1,4-butanediol diglycidyl ether (BDDE) and polyethylene glycol 400 (PEG400) in any proportion; in this step, the mass ratio of the sodium hyaluronate molecules in the sodium hyaluronate solution to the mixed cross-linking agent is 12-40:1;

[0047] The specific process of the cross-linking reaction is as follows: after adding the mixed cross-linking agent to the sodium hyaluronate solution, stirring the reaction for 10-20 minutes, and then standing the reaction for 10-20 hours to obtain a cross-linked sodium hyaluronate gel; wherein the temperature of the cross-linking reaction is 30-50°C;

[0048] S3: dialyzing the cross-linked sodium hyaluronate gel to prepare a water-swelling gel;

[0049] The specific process of step S3 is:

[0050] S31: Cut the cross-linked sodium hyaluronate gel into pieces with a volume of 1-3 cm 3 The block raw material is placed in a batching tank after cutting the cross-linked sodium hyaluronate gel;

[0051] S32: adding a buffer solution into the mixing tank, and continuously stirring the cut cross-linked sodium hyaluronate gel in the mixing tank at a rate of 5-20 r / min; wherein the buffer solution is a phosphate buffer solution containing sodium chloride; wherein the mass fraction of sodium chloride in the buffer solution is 0.5-1.5%;

[0052] S33: After stirring for 6 hours, the buffer solution in the batching tank is discharged to complete a single dialysis process;

[0053] S34: Repeat steps S32-S336-10 times to obtain a water-absorbing swelling gel;

[0054] S4: After the water-swelling gel is ground and sterilized by high-temperature wet heat, the cross-linked sodium hyaluronate gel for injection is obtained;

[0055] The specific process of step S4 is as follows: the water-swelling gel is put into a colloid mill for grinding, the grinding is performed 2-3 times, each grinding lasts for 10-20 minutes, and after the grinding is completed, the ground water-swelling gel is sterilized at 115-125° C. for 10-20 minutes to obtain a cross-linked sodium hyaluronate gel for injection.

[0056] like Figure 1 As shown, an embodiment of the second aspect of the present invention provides a preparation device for a method of preparing a cross-linked sodium hyaluronate gel for injection, comprising a batching tank 1, a cleaning tank 2, a saline tank 3, a saline tank 4, a saline pump 5 and a saline pump 6, wherein the saline tank 3 and the saline tank 4 are both connected to the water inlet end of the saline pump 5 through a pipeline, and the discharge ends of the saline pump 5 and the saline pump 6 are both connected to the batching tank 1, and the discharge end of the cleaning tank 2 is connected to the water inlet end of the saline pump 6;

[0057] The bottom of the batching tank 1 is connected to a drain pipe, and a drain valve is provided on the drain pipe;

[0058] The feed ports of brine tank 1 3 and brine tank 2 4 are both connected with pure water delivery pipelines;

[0059] The preparation device also includes a cross-linking reaction tank;

[0060] Among them, the saline tank 1 3 and the saline tank 2 4 are used for preparing the buffer solution required for dialysis of the cross-linked sodium hyaluronate gel after the cross-linking reaction. After the cross-linking reaction process, purified water is input into the saline tank 1 3 and the saline tank 2 4 through the pure water delivery pipeline for preparing the buffer solution;

[0061] The saline pump 5 is used to deliver the buffer solution into the batching tank 1 to complete the cyclic dialysis process;

[0062] The cleaning tank 2 is used to prepare a 0.1M NaOH solution, and the prepared 0.1M NaOH solution is transported to the batching tank 1 via a brine pump 2 6 for cleaning the batching tank 1 after the dialysis is completed;

[0063] The batching tank 1 is used for dialyzing the cross-linked sodium hyaluronate gel after the cross-linking reaction. The cross-linked sodium hyaluronate gel is fed into the batching tank 1 through the feeding port on the top of the batching tank 1, and the buffer solution prepared in the brine tank 3 and the brine tank 4 is transported to the batching tank 1 through the brine pump 5. The stirring paddle is turned on to dialyze the cross-linked sodium hyaluronate gel in the batching tank 1. After a single dialysis is completed, the drain valve at the bottom of the batching tank 1 is opened to discharge the buffer solution, and then the drain valve is closed, and the buffer solution is re-input into the batching tank 1, and then a secondary dialysis is performed. Repeated multiple times to complete the dialysis process. After the dialysis process is completed, the dialyzed cross-linked sodium hyaluronate gel, that is, the water-swelled gel, is discharged through the discharge port at the bottom of the batching tank 1 to proceed to the next process.

[0064] The preparation device is used to implement the preparation method of the above-mentioned cross-linked sodium hyaluronate gel for injection. When the preparation device is used to implement the preparation method of the above-mentioned cross-linked sodium hyaluronate gel for injection, the preparation method comprises the following steps:

[0065] Step a: injecting alkali solution into a cross-linking reaction tank, dissolving sodium hyaluronate molecules with a molecular weight greater than 2 million Daltons in the alkali solution in the cross-linking reaction tank, and preparing a sodium hyaluronate solution; wherein the alkali solution is a sodium hydroxide solution with a concentration of 0.5-2%;

[0066] Step b: adding a mixed cross-linking agent to the sodium hyaluronate solution to carry out a cross-linking reaction to obtain a cross-linked sodium hyaluronate gel; wherein the mixed cross-linking agent is a mixture of 1,4-butanediol diglycidyl ether (BDDE) and polyethylene glycol 400 (PEG400) in any proportion; in this step, the mass ratio of the sodium hyaluronate molecules in the sodium hyaluronate solution to the mixed cross-linking agent is 12-40:1;

[0067] The specific process of the cross-linking reaction is as follows: after adding the mixed cross-linking agent to the sodium hyaluronate solution, stirring the reaction for 10-20 minutes, and then standing the reaction for 10-20 hours to obtain a cross-linked sodium hyaluronate gel; wherein the temperature of the cross-linking reaction is 30-50°C;

[0068] This step is all carried out in a cross-linking reaction tank;

[0069] Step c: dialyzing the cross-linked sodium hyaluronate gel to prepare a water-swellable gel;

[0070] The specific process of step c is:

[0071] Step c1: Cut the cross-linked sodium hyaluronate gel into pieces with a volume of 1-3 cm3 The block raw material is placed in a batching tank after cutting the cross-linked sodium hyaluronate gel;

[0072] Step c2: adding a buffer solution into the batching tank, and continuously stirring the cut cross-linked sodium hyaluronate gel in the batching tank at a rate of 5-20 r / min; wherein the buffer solution is a phosphate buffer solution containing sodium chloride; wherein the mass fraction of sodium chloride in the buffer solution is 0.5-1.5%; wherein the buffer solution is prepared in a saline tank 1 3 and a saline tank 2 4, and a saline tank 1 3 and a saline tank 2 4 are provided, and the buffer solution can be prepared alternately, and multiple dialysis processes can be completed, thereby speeding up the experimental progress;

[0073] Step c3: After stirring for 6 hours, the buffer solution in the batching tank is discharged to complete a single dialysis process;

[0074] Step c4: repeat steps c2 to c36-10 times to obtain a water-swelling gel;

[0075] S4: After the water-swelling gel is ground and sterilized by high-temperature wet heat, the cross-linked sodium hyaluronate gel for injection is obtained;

[0076] The specific process of step S4 is as follows: the water-swelling gel is put into a colloid mill for grinding, the grinding is performed 2-3 times, each grinding lasts for 10-20 minutes, and after the grinding is completed, the ground water-swelling gel is sterilized at 115-125° C. for 10-20 minutes to obtain a cross-linked sodium hyaluronate gel for injection.

[0077] The following are specific examples. Unless otherwise specified, the raw materials in the following examples can be obtained commercially.

[0078] Example 1

[0079] This embodiment provides a method for preparing a cross-linked sodium hyaluronate gel for injection, the preparation method comprising the following steps:

[0080] S1: Purchase 50 g of sodium hyaluronate with a molecular weight greater than 2 million Daltons and dissolve it in 250 mL of 1% NaOH solution to obtain a sodium hyaluronate solution with a concentration of 200 mg / mL;

[0081] S2: Add 2.5 g of a mixed solution of BDDE and PEG400 in equal proportions to the above solution, stir for 15 min at 40°C, and then allow to react for 14 hours to obtain a cross-linked sodium hyaluronate gel;

[0082] Wherein, step S1 and step S2 are both carried out in a cross-linking reaction tank;

[0083] S3: Cut the cross-linked sodium hyaluronate gel into 1 cm 3Put the small pieces about 1 / 2 inch into batching tank 1;

[0084] S4: injecting 20L of a buffer solution (pH=7.0) containing NaCl into the batching tank 1 and stirring at a rate of 10 rpm; wherein the buffer solution is a PBS solution containing NaCl, and the mass fraction of NaCl in the buffer solution is 0.9%;

[0085] The buffer solution is prepared in the salt water tank 1 3 and the salt water tank 2 4;

[0086] S4: After stirring for 6 hours, the buffer solution in the batching tank is discharged to complete a single dialysis process;

[0087] S5: Repeat steps S4-S58 times to prepare a water-swellable gel;

[0088] S6: Filter and remove excess buffer in the water-swelling gel, put the water-swelling gel into a colloid mill and grind it twice, and then sterilize the ground gel at 121° C. for 15 minutes to obtain a cross-linked sodium hyaluronate gel for injection.

[0089] Example 2

[0090] This embodiment provides a method for preparing a cross-linked sodium hyaluronate gel for injection, the preparation method comprising the following steps:

[0091] S1: Purchase 50 g of sodium hyaluronate with a molecular weight greater than 2 million Daltons and dissolve it in 200 mL of 0.5% NaOH solution to obtain a sodium hyaluronate solution with a concentration of 250 mg / mL;

[0092] S2: Add 4.17 g of a mixed solution of BDDE and PEG400 in equal proportions to the above solution, stir for 20 min at 40°C, and then allow to react for 10 hours to obtain a cross-linked sodium hyaluronate gel;

[0093] Wherein, step S1 and step S2 are both carried out in a cross-linking reaction tank;

[0094] S3: Cut the cross-linked sodium hyaluronate gel into 2 cm 3 Put the small pieces about 1 / 2 inch into batching tank 1;

[0095] S4: injecting 20L of a buffer solution (pH=7.0) containing NaCl into the batching tank 1 and stirring at a rate of 5 rpm; wherein the buffer solution is a PBS solution containing NaCl, and the mass fraction of NaCl in the buffer solution is 0.5%;

[0096] The buffer solution is prepared in the salt water tank 1 3 and the salt water tank 2 4;

[0097] S4: After stirring for 6 hours, the buffer solution in the batching tank is discharged to complete a single dialysis process;

[0098] S5: Repeat steps S4-S5 6 times to prepare a water-swellable gel;

[0099] S6: Filter and remove excess buffer in the water-swelling gel, put the water-swelling gel into a colloid mill and grind it twice, and then sterilize the ground gel at 121° C. for 15 minutes to obtain a cross-linked sodium hyaluronate gel for injection.

[0100] Example 3

[0101] This embodiment provides a method for preparing a cross-linked sodium hyaluronate gel for injection, the preparation method comprising the following steps:

[0102] S1: Purchase 50 g of sodium hyaluronate with a molecular weight greater than 2 million Daltons and dissolve it in 500 mL of 2% NaOH solution to obtain a sodium hyaluronate solution with a concentration of 100 mg / mL;

[0103] S2: Add 1.25 g of a mixed solution of BDDE and PEG400 in equal proportions to the above solution, stir for 10 min at 50° C., and then allow to react for 20 hours to obtain a cross-linked sodium hyaluronate gel;

[0104] Wherein, step S1 and step S2 are both carried out in a cross-linking reaction tank;

[0105] S3: Cut the cross-linked sodium hyaluronate gel into 3 cm 3 Put the small pieces about 1 / 2 inch into batching tank 1;

[0106] S4: injecting 20L of a buffer solution (pH=7.0) containing NaCl into the batching tank 1 and stirring at a rate of 20 rpm; wherein the buffer solution is a PBS solution containing NaCl, and the mass fraction of NaCl in the buffer solution is 1.5%;

[0107] The buffer solution is prepared in the salt water tank 1 3 and the salt water tank 2 4;

[0108] S4: After stirring for 6 hours, the buffer solution in the batching tank is discharged to complete a single dialysis process;

[0109] S5: Repeat steps S4-S5 10 times to prepare a water-swellable gel;

[0110] S6: Filter and remove excess buffer in the water-swelling gel, put the water-swelling gel into a colloid mill and grind it twice, and then sterilize the ground gel at 121° C. for 15 minutes to obtain a cross-linked sodium hyaluronate gel for injection.

[0111] Experimental example

[0112] After freeze-drying the cross-linked sodium hyaluronate gel for injection prepared in Example 1-3, potassium bromide was used for tableting, and the infrared spectrophotometry method was used for determination according to the general rule 0402 of Part IV of the 2020 edition of the Pharmacopoeia of the People's Republic of China, and the spectrum was compared with the spectrum of the reference product to confirm the cross-linking degree of the finished product;

[0113] The cross-linked sodium hyaluronate gel for injection prepared by the bacterial endotoxin test method in accordance with the 2020 edition of the Pharmacopoeia of the People's Republic of China, Part IV, General Rules 1143, has a bacterial endotoxin content of less than 0.5 EU / mL;

[0114] The cross-linked sodium hyaluronate gel for injection was tested by the direct inoculation method in accordance with the sterility inspection method in General Chapter 1101 of Part IV of the 2020 edition of the Pharmacopoeia of the People's Republic of China. The positive control bacteria was Staphylococcus aureus (CMCC(B)26003), and the product was sterile.

[0115] The present invention provides a method for preparing a cross-linked sodium hyaluronate gel for injection, which adopts sodium hyaluronate with a molecular weight greater than 2 million as a main raw material, reduces the amount of a cross-linking agent, and adopts a mixed cross-linking agent to improve the degree of cross-linking.

[0116] The present invention also provides a preparation device for a method for preparing a cross-linked sodium hyaluronate gel for injection, which is used for preparing the cross-linked sodium hyaluronate gel for injection. The preparation device ensures that in the method for preparing the cross-linked sodium hyaluronate gel for injection, the cross-linking reaction and dialysis are both carried out under closed conditions, thereby reducing the possibility of environmental microbial contamination, thereby ensuring that the prepared cross-linked sodium hyaluronate gel for injection meets the preparation requirements of injection products.

[0117] In the description of this specification, the description with reference to the terms "one embodiment", "example", "specific example", etc. means that the specific features, structures, materials or characteristics described in conjunction with the embodiment or example are included in at least one embodiment or example of the present invention. In this specification, the schematic representation of the above terms does not necessarily refer to the same embodiment or example. Moreover, the specific features, structures, materials or characteristics described can be combined in any one or more embodiments or examples in a suitable manner.

[0118] The above shows and describes the basic principles, main features and advantages of the present invention. Those skilled in the art should understand that the present invention is not limited to the above embodiments, and the above embodiments and descriptions are only for explaining the principles of the present invention. Without departing from the spirit and scope of the present invention, the present invention may have various changes and improvements, and these changes and improvements all fall within the scope of the present invention to be protected.

Claims

1. A method for preparing cross-linked sodium hyaluronate gel for injection, characterized in that: The preparation method comprises the following steps: S1: injecting alkaline solution into a cross-linking reaction tank, dissolving sodium hyaluronate molecules in the alkaline solution, and preparing a sodium hyaluronate solution; S2: adding a mixed cross-linking agent to the sodium hyaluronate solution to perform a cross-linking reaction to obtain a cross-linked sodium hyaluronate gel; S3: dialyzing the cross-linked sodium hyaluronate gel to prepare a water-swellable gel; S4: After the water-swelling gel is ground and sterilized by high-temperature wet heat, the cross-linked sodium hyaluronate gel for injection is obtained.

2. The method for preparing a cross-linked sodium hyaluronate gel for injection according to claim 1, characterized in that: In step S1, the molecular weight of the sodium hyaluronate molecule is greater than 2 million Daltons.

3. The method for preparing a cross-linked sodium hyaluronate gel for injection according to claim 1, characterized in that: In step S1, the alkali solution is a sodium hydroxide solution with a concentration of 0.5-2%; In the sodium hyaluronate solution, the mass ratio of sodium hyaluronate molecules to alkali solution is 1:(4-10).

4. The method for preparing a cross-linked sodium hyaluronate gel for injection according to claim 1, characterized in that: The mixed cross-linking agent is a mixture of 1,4-butanediol diglycidyl ether and polyethylene glycol 400 mixed in any proportion; In step S2, the mass ratio of the sodium hyaluronate molecules to the mixed cross-linking agent in the sodium hyaluronate solution is 12-40:

1.

5. The method for preparing a cross-linked sodium hyaluronate gel for injection according to claim 1, characterized in that: The specific process of step S2 is: after adding the mixed cross-linking agent to the sodium hyaluronate solution, heating to 30-50° C., stirring for 10-20 minutes, and then standing for 10-20 hours to obtain a cross-linked sodium hyaluronate gel.

6. The method for preparing a cross-linked sodium hyaluronate gel for injection according to claim 1, characterized in that: The specific process of step S3 is as follows: S31: Cut the cross-linked sodium hyaluronate gel into pieces with a volume of 1-3 cm 3 The block raw material is placed in a batching tank after cutting the cross-linked sodium hyaluronate gel; S32: adding a buffer solution into the mixing tank, and continuously stirring the cut cross-linked sodium hyaluronate gel in the mixing tank at a rate of 5-20 r / min; S33: After stirring for 6 hours, the buffer solution in the batching tank is discharged to complete a single dialysis process; S34: Repeat steps S32-S336-10 times to obtain a water-absorbing and swelling gel.

7. The method for preparing a cross-linked sodium hyaluronate gel for injection according to claim 1, characterized in that: The buffer solution is a phosphate buffer solution containing sodium chloride; The mass fraction of sodium chloride in the buffer solution is 0.5-1.5%.

8. The method for preparing a cross-linked sodium hyaluronate gel for injection according to claim 1, characterized in that: The specific process of step S4 is: putting the water-swelling gel into a colloid mill for grinding, grinding for 2-3 times, each grinding for 10-20 minutes, and after the grinding, sterilizing the ground water-swelling gel at 115-125° C. for 10-20 minutes to obtain a cross-linked sodium hyaluronate gel for injection.

9. A preparation device for the method for preparing the cross-linked sodium hyaluronate gel for injection according to any one of claims 1 to 8, characterized in that: It comprises a batching tank (1), a cleaning tank (2), a salt water tank 1 (3), a salt water tank 2 (4), a salt water pump 1 (5) and a salt water pump 2 (6); the salt water tank 1 (3) and the salt water tank 2 (4) are both connected to the water inlet end of the salt water pump 1 (5) through a pipeline; the discharge ends of the salt water pump 1 (5) and the salt water pump 2 (6) are both connected to the batching tank (1); and the discharge end of the cleaning tank (2) is connected to the water inlet end of the salt water pump 2 (6); The bottom of the batching tank (1) is connected to a drain pipe, and a drain valve is provided on the drain pipe; The feed inlets of the brine tank 1 (3) and the brine tank 2 (4) are both connected to a pure water delivery pipeline.

10. The preparation device of the method for preparing the cross-linked sodium hyaluronate gel for injection according to claim 9, characterized in that: The preparation device also includes a cross-linking reaction tank.

Citation Information

Cited By

  • Method for preparing polysaccharide sodium hyaluronate composite gel by pre-crosslinking method

    CN119859286A